Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aastrom Biosciences, Inc.
Third NIH grant received during fiscal quarter for stem cell research
July 30th, 2003
Aastrom Biosciences, Inc., (ASTM) announced that it has received a Small Business Innovation Research phase I grant from the U.S. National Institutes of Health (NIH) entitled "Clinical-Scale Production of Osteoprogenitor Cells." The grant will support investigations to expand the company's development of effective stem cell-based approaches for the regeneration of bone in patients requiring a bone graft treatment. Bone grafting is required annually in over one million people in the United States and Europe, for orthopedic procedures such as fusion of spine vertebrae, repair of major leg fractures, and other bone repair applications. The 6-month...
Source: Biotech Week (2003-07-30)
|
